NCT03711188 2024-04-29
A Study of IMM-101 in Combination With Checkpoint Inhibitor Therapy in Advanced Melanoma
Immodulon Therapeutics Ltd
Phase 2 Completed
Clinical Trials
3 trialsNCT01559818 2023-06-22
A Long Term Follow up Study for Patients Who Previously Took Part in the Phase I Study IMM-101-001
Immodulon Therapeutics Ltd
Phase 1/2 Terminated
NCT01308762 2012-12-06
A Clinical Study, to Evaluate the Safety and Tolerability of Intradermal IMM-101 in Adult Melanoma Cancer Patients
Immodulon Therapeutics Ltd
Phase 1 Completed